Evidence map›Paper›PMID 34363322›Full record

ReviewActa ophthalmologica2022

Vascular biomarkers from optical coherence tomography angiography and glaucoma: where do we stand in 2021?

Joshua D Shin, Amber T Wolf, Alon Harris, Alice Verticchio Vercellin, Brent Siesky, Lucas W Rowe, Michelle Packles, Francesco Oddone

Open access · greenAbstract readReview
In one paragraph

Review in Acta ophthalmologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Study of the impact of the vascular systemic risk factors on peripapillary vascular density by optical coherence tomography angiography.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effects of Tafluprost on Ocular Blood Flow.Ophthalmology and therapy · 2022
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Joshua D ShinSchool of Medicine, New York Medical College, Valhalla, NY, USA.
Amber T WolfIcahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Alon HarrisIcahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.ORCID https://orcid.org/0000-0001-8770-3726
Alice Verticchio VercellinIcahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Brent SieskyIcahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Lucas W RoweIndiana University School of Medicine, Indianapolis, IN, USA.
Michelle PacklesIcahn School of Medicine at Mount Sinai Hospital, New York, NY, USA.
Francesco OddoneIRCCS -Fondazione Bietti, Rome, Italy.
Mount Sinai Hospital · USFondazione G.B. Bietti · ITIndiana University School of MedicineIndra (Spain) · ESNew York Medical College · US

Funding

Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamicsR01EY030851 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ARCIERO, JULIA, HARRIS, ALON · 2020 to 2023
$1.3M
NEI NIH HHS R01 EY030851NIH HHS R01EY030851NSF DMS 1853222/2021192Research to Prevent Blindness, NY
6 · The paper itself

Abstract

Biomarkers of ocular blood flow originating from a wide variety of imaging modalities have been associated with glaucoma onset and progression for many decades. Advancements in imaging platforms including optical coherence tomography angiography (OCTA) have provided the ability to quantify vascular changes in glaucoma patients, alongside traditional measures such as retinal nerve fibre layer thickness and optic nerve head structure. Current literature on vascular biomarkers, as measured by OCTA, indicates significant relationships between glaucoma and blood flow and capillary density in the retina and ONH. The data currently available, however, are highly diverse and lack robust longitudinal data on OCTA vascular outcomes and glaucoma progression. Herein we discuss and summarize the relevant current literature on OCTA vascular biomarkers and glaucoma reviewed through March 1, 2021. Associations between OCTA vascular biomarkers and clinical structural and functional glaucoma outcomes as well as differences between glaucoma patients and healthy controls are reviewed and summarized. The available data identify significantly decreased flow density, flow index and vessel density in the ONH, peripapillary vascular layer and macula of glaucoma patients compared with controls. Whole image vessel density is also significantly decreased in glaucoma patients compared with controls, and this outcome has been found to correspond to severity of visual field loss. OCTA vascular biomarkers alongside clinical structural outcomes may aid in assessing overall risk for glaucoma in patients.

Indexed as

BiomarkersFluorescein AngiographyGlaucomaHumansMacula LuteaOptic DiskRetinal VesselsTomography, Optical CoherenceBiomarkersglaucomaimagingOCTAvascular biomarkers

Identifiers

PMID34363322
PMCPMC8920047
OpenAlexW3191067384

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.